BetterLife Pharma Inc.
CSE: BETR, OTCQB: BETRF, FRA: NPAU
Company Overview
BetterLife Pharma Inc. is an emerging biotechnology company engaged in the development and commercialization of next generation psychedelic products for the treatment of mental disorders. Utilizing drug delivery platform technologies, BetterLife is also refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.
Financial Highlights
$0
Revenue (ttm)
-$22,808
Gross Profit (ttm)
-$0.16
Diluted EPS (ttm)
Management Team
Dr. Ahmad Doroudian Ph.D.
Founder, CEO & Chairman
Ms. Moira Ong C.A., CPA, CA, CFA
Chief Financial Officer
Dr. Hooshmand Sheshbaradaran Ph.D.
Chief Operating Officer
Mr. Scott Rudge Ph.D.
Head of CMC
Anthony Calandra Ph.D.
Head of Regulatory
Dr. Abdi Ghaffari Ph.D.
Head of Preclinical & Toxicology
Key Highlights
Market Capitalization
$0
Shares Outstanding
0
Shares Short (% of Float)
()
Insider Ownership
9%